TY - JOUR
T1 - Functional location of the language cortical areas in focal refractory epilepsy using the conventional, selective, and supraselective Wada test
AU - González-Acosta, Carlos A.
AU - Tolosa-Gaviria, Carlos R.
AU - Herrera-Trujillo, Alejandro
AU - Dorado-Ramírez, Carlos A.
AU - Escobar-Rojas, William
AU - Rojas-Cerón, Christian A.
AU - Becerra-Hernández, Lina V.
AU - Buriticá-Ramírez, Efraín
AU - Pedroza-Campo, Alfredo
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/5/1
Y1 - 2025/5/1
N2 - In refractory focal epilepsy, resective surgery offers an alternative for seizure control. However, there is a risk of language deterioration when the epileptogenic zone involves an eloquent cortical region. The Wada test involves the insertion of a catheter through the internal carotid artery and the injection of a short-acting anesthetic, resulting in transient loss of hemisphere function. While its specificity is high, its sensitivity is reduced, despite its limited or absent spatial resolution. Additionally, the generalized action of the anesthetic may lead to misinterpretations due to global cognitive arrest, particularly in patients with baseline deficits. The aim of this report was to prove the refinement of the selective and supraselective protocols, as well as their contribution to overcoming these disadvantages. The procedure began by placing a microcatheter in progressively more distal irrigation sites, according to the required technique, gradually performing angiography with contrast medium. Tissue perfusion allowed the identification of the cerebral parenchyma where the anesthetic would act. After injection, the assessment of neurocognitive changes was conducted. The characterization of language patterns was performed, delineating indispensable eloquent zones and dispensable eloquent zones, irrespective of the patients’ cognitive condition. There was concordance between the findings and post-surgical results. The selective and supraselective Wada test surpasses the disadvantages of the conventional method and proves decisive in surgical planning and decision-making.
AB - In refractory focal epilepsy, resective surgery offers an alternative for seizure control. However, there is a risk of language deterioration when the epileptogenic zone involves an eloquent cortical region. The Wada test involves the insertion of a catheter through the internal carotid artery and the injection of a short-acting anesthetic, resulting in transient loss of hemisphere function. While its specificity is high, its sensitivity is reduced, despite its limited or absent spatial resolution. Additionally, the generalized action of the anesthetic may lead to misinterpretations due to global cognitive arrest, particularly in patients with baseline deficits. The aim of this report was to prove the refinement of the selective and supraselective protocols, as well as their contribution to overcoming these disadvantages. The procedure began by placing a microcatheter in progressively more distal irrigation sites, according to the required technique, gradually performing angiography with contrast medium. Tissue perfusion allowed the identification of the cerebral parenchyma where the anesthetic would act. After injection, the assessment of neurocognitive changes was conducted. The characterization of language patterns was performed, delineating indispensable eloquent zones and dispensable eloquent zones, irrespective of the patients’ cognitive condition. There was concordance between the findings and post-surgical results. The selective and supraselective Wada test surpasses the disadvantages of the conventional method and proves decisive in surgical planning and decision-making.
KW - Atypical language lateralization
KW - Epileptogenic zone
KW - Refractory epilepsy
KW - Selective technique
KW - Supraselective technique
KW - WADA test
UR - http://www.scopus.com/inward/record.url?scp=86000778512&partnerID=8YFLogxK
U2 - 10.1016/j.brainres.2025.149564
DO - 10.1016/j.brainres.2025.149564
M3 - Article
AN - SCOPUS:86000778512
SN - 0006-8993
VL - 1854
JO - Brain Research
JF - Brain Research
M1 - 149564
ER -